We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
AUM
$2.7B
AUM Growth
-$1.42B
Cap. Flow
-$1.49B
Cap. Flow %
-55.02%
Top 10 Hldgs %
60.52%
Holding
69
New
16
Increased
13
Reduced
16
Closed
22

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$164M
2
DISH
DISH Network Corp.
DISH
+$132M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$119M
4
IT icon
Gartner
IT
+$114M
5
CPAY icon
Corpay
CPAY
+$107M

Sector Composition

Rank Sector Weight
1 Consumer Staples 13.22%
2 Healthcare 13.15%
3 Financials 6.5%
4 Technology 6.39%
5 Industrials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INCY icon
26
Incyte
INCY
$24.3B
$27.9M 1.03%
294,607
+39,607
+16% +$4.14M
EVHC
27
DELISTED
Envision Healthcare Holdings Inc
EVHC
$26.1M 0.97%
+756,259
New +$26.4M
V icon
28
Visa
V
$678B
$25.7M 0.95%
+225,000
New +$24.8M
MRK icon
29
Merck
MRK
$322B
$23.9M 0.88%
+445,400
New +$24.7M
HUM icon
30
Humana
HUM
$44.4B
$22.3M 0.83%
+90,000
New +$22.2M
GPP
31
DELISTED
Green Plains Partners LP
GPP
$21.6M 0.8%
1,153,423
-1,209,043
-51% -$23.2M
GWPH
32
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$19.6M 0.72%
+148,327
New +$17.4M
WBD icon
33
Warner Bros
WBD
$64.1B
$18.7M 0.69%
834,179
-3,050,821
-79% -$59.6M
RDUS
34
CALL
DELISTED
Radius Health, Inc.
RDUS
$15.9M 0.59%
500,000
-250,000
-33% -$7.84M
RSG icon
35
Republic Services
RSG
$64.8B
$13.5M 0.5%
+200,000
New +$12.9M
MIC
36
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$11.8M 0.44%
183,575
BSX icon
37
Boston Scientific
BSX
$66.9B
$11.2M 0.41%
+450,000
New +$12.4M
FOLD
38
CALL
DELISTED
Amicus Therapeutics
FOLD
$10.1M 0.37%
700,000
+450,000
+180% +$6.18M
FOLD
39
PUT
DELISTED
Amicus Therapeutics
FOLD
$10.1M 0.37%
700,000
+450,000
+180% +$6.18M
POST icon
40
Post Holdings
POST
$4.17B
$9.92M 0.37%
191,283
-1,457,441
-88% -$77.5M
LDOS icon
41
Leidos
LDOS
$14.1B
$5M 0.19%
77,477
-423,952
-85% -$26.6M
GBT
42
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.95M 0.18%
+125,787
New +$4.7M
BSX icon
43
CALL
Boston Scientific
BSX
$66.9B
$4.09M 0.15%
+165,200
New +$4.56M
VYGR icon
44
Voyager Therapeutics
VYGR
$185M
$3.82M 0.14%
+230,000
New +$3.94M
KRYS icon
45
Krystal Biotech
KRYS
$10.3B
$2.65M 0.1%
252,348
+2,348
+0.9% +$23.5K
NITE
46
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$2.24M 0.08%
170,952
+19,952
+13% +$359K
NMRK icon
47
Newmark Group
NMRK
$2.63B
$795K 0.03%
+50,000
New +$765K
AMCX icon
48
AMC Global Media
AMCX
$492M
-817,016
Closed -$47.8M
CTSH icon
49
CALL
Cognizant
CTSH
$24.2B
-1,000,000
Closed -$72.5M
DBVT
50
DBV Technologies
DBVT
$805M
-11,500
Closed -$4.88M

Similar funds

Tourbillon Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Tourbillon Capital Partners held 69 positions worth $2.7B, down 35% from $4.13B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Tourbillon Capital Partners withdrew a net $1.49B in Q4 2017, closing 22 positions and reducing 16 holdings. Its most notable exit was eBay, an estimated $164M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 13% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Tourbillon Capital Partners opened a new position in Howmet Aerospace worth $97.3M.

  • Tourbillon Capital Partners's largest Q4 2017 buy was Howmet Aerospace: 4,654,447 shares worth $97.3M.
  • Tourbillon Capital Partners added most to Spectrum Brands in Q4 2017, an estimated $37.3M increase.
  • Tourbillon Capital Partners's biggest Q4 2017 reduction was DISH Network Corp., cutting an estimated $132M.
  • Tourbillon Capital Partners fully exited eBay in Q4 2017, selling an estimated $164M.
  • Tourbillon Capital Partners's ten largest holdings make up 61% of its $2.7B portfolio in Q4 2017.
  • Tourbillon Capital Partners opened 16 new positions and closed 22 in Q4 2017.
  • Tourbillon Capital Partners's portfolio value fell 35% quarter-over-quarter to $2.7B.

Based on Tourbillon Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.